Evaluating the CRP Interactome: Insights into Possible Novel Roles in Cellular Signaling and Tumorigenicity
Authors:
- Alison GerhardtAGAlison Gerhardt
- Dlen NanakaliyDNDlen Nanakaliy
- Harnish D. ShahHSHarnish D. Shah
- Syed SarfarazSSSyed Sarfaraz
- Charlotte MadiganCMCharlotte Madigan
- Makenna DowningMDMakenna Downing
- Robert P. ElliottRERobert P. Elliott
- Rafid DiptoRDRafid Dipto
- Bella VrapciuBVBella Vrapciu
- Joseph W. NoetzelJNJoseph W. Noetzel
- Jessica ArmasJAJessica Armas
- Ayesha AhmedAAAyesha Ahmed
Open Access
- 28 November 2025
- journal article
- review article
- Published by MDPI AG in Current Issues in Molecular Biology
- Vol. 47 (12) , 1003
Abstract
C-reactive protein (CRP) is a well-known acute phase reactant and putative biomarker for advancing and chronically established inflammation. Its biological activity across its multiple isoforms plays various roles in the initiation, potentiation, and resolution of inflammation. Its molecular signaling within the tissue microenvironment regulates cell–cell communication across cell types (e.g., epithelial cells, endothelial cells, fibroblasts, adipocytes, and immune cells) and affects the development of conditions such as cancer that are subject, at least in part, to inflammatory signaling. Considering the dynamic nature of CRP in modulating disease progression, and the growing evidence of the context-dependent direct molecular activity of CRP on regulating intra- and inter-cellular signaling, it is critical to further understand how this integral molecule alters cell signaling pathways. Although the ability of CRP to directly interact with some extracellular matrix proteins involved with inflammation and disease has been reported as early as the mid-1980s, recent advances in unbiased proteomics have revealed a broader interactome of protein–protein interactions (PPIs) involving CRP. The present study evaluates the CRP PPIs identified to date and explores the potential novel regulatory capacity of CRP on multiple key cellular functions in metabolism and cell–cell signaling, offering an updated framework of the possible biological activities of CRP relevant to tumorigenic processes.Keywords
This publication has 148 references indexed in Scilit:
- HIF-1 and HIF-2 in cancer: structure, regulation, and therapeutic prospectsCellular and Molecular Life Sciences, 2025
- Altered glycosylation in cancer: molecular functions and therapeutic potentialCancer Communications, 2024
- C-reactive protein levels, the prognostic nutritional index, and the lactate dehydrogenase-to-lymphocyte ratio are important prognostic factors in primary central nervous system lymphoma: a single-center study of 223 patientsNeurosurgical Review, 2023
- High‐sensitivity C‐reactive protein and risk of type 2 diabetes: A nationwide cohort study and updated meta‐analysisDiabetes/Metabolism Research and Reviews, 2021
- The BioGRID database: A comprehensive biomedical resource of curated protein, genetic, and chemical interactionsProtein Science, 2020
- Keratan Sulphate in the Tumour Environment2020
- HIF‐1 at the crossroads of hypoxia, inflammation, and cancerInternational Journal of Cancer, 2015
- Hypoxia negatively regulates heparan sulfatase 2 expression in renal cancer cell linesMolecular Carcinogenesis, 2011
- An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown2010
- Characteristics of the binding of human C‐reactive protein (CRP) to lamininJournal of Cellular Biochemistry, 1989